Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Kentucky · 2025 Regular Session · Bill

HB 75: AN ACT relating to undesignated glucagon.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 75 is a bill introduced in the Kentucky House on January 7, 2025. According to its official title, it concerns: AN ACT relating to undesignated glucagon. Most recent recorded action (February 4, 2025): to Health Services (H).

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Create new sections of KRS Chapter 217 to define terms; permit health care practitioners to prescribe and dispense undesignated glucagon in the name of a school or to a trained individual; permit trained individuals to receive, possess, and administer undesignated glucagon during diabetic medical emergencies; permit schools to stock undesignated glucagon; provide for immunity from civil liability for any personal injury resulting from good faith actions to use undesignated glucagon to treat diabetic medical emergencies.

Sponsors

NameRolePartyChamberDistrict
No sponsor recorded in source data.

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. to Health Services (H)
  2. to Committee on Committees (H)
  3. introduced in House

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source